Inflammatix is a series c plus startup based in United States. 2 investors tracked.
Inflammatix is a startup based in the United States. Brouky records 2 investors associated with the company.
Inflammatix is a molecular diagnostics company developing novel tests to improve the diagnosis and management of acute infections and inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.